NovelStem International (NSTM) and Its Peers Head to Head Review

NovelStem International (OTCMKTS:NSTM) is one of 26 publicly-traded companies in the “Retail stores, not elsewhere classified” industry, but how does it compare to its peers? We will compare NovelStem International to related businesses based on the strength of its dividends, analyst recommendations, profitability, earnings, institutional ownership, risk and valuation.

Risk and Volatility

NovelStem International has a beta of 0.42, indicating that its stock price is 58% less volatile than the S&P 500. Comparatively, NovelStem International’s peers have a beta of 0.82, indicating that their average stock price is 18% less volatile than the S&P 500.

Earnings and Valuation

This table compares NovelStem International and its peers gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
NovelStem International	$10,000.00	-$4.19 million	-0.30
NovelStem International Competitors	$49.55 billion	$125.40 million	6.40

NovelStem International’s peers have higher revenue and earnings than NovelStem International. NovelStem International is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a summary of current ratings and target prices for NovelStem International and its peers, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NovelStem International	0	0	0	0	N/A
NovelStem International Competitors	88	811	1393	55	2.60

As a group, “Retail stores, not elsewhere classified” companies have a potential upside of 12.67%. Given NovelStem International’s peers higher possible upside, analysts clearly believe NovelStem International has less favorable growth aspects than its peers.

Profitability

This table compares NovelStem International and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NovelStem International	-9,166.67%	N/A	-73.18%
NovelStem International Competitors	-25.06%	-60.82%	-0.94%

Institutional & Insider Ownership

29.3% of shares of all “Retail stores, not elsewhere classified” companies are held by institutional investors. 13.6% of NovelStem International shares are held by insiders. Comparatively, 16.9% of shares of all “Retail stores, not elsewhere classified” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

NovelStem International peers beat NovelStem International on 9 of the 10 factors compared.

About NovelStem International

NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.